Layered Screening and Contact-Limiting Interventions Are Necessary to Reduce SARS-Cov-2 Outbreak Risks in Large Urban Jails.
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
04 10 2023
04 10 2023
Historique:
received:
17
11
2022
accepted:
09
06
2023
medline:
6
10
2023
pubmed:
6
9
2023
entrez:
5
9
2023
Statut:
epublish
Résumé
Highly transmissible infections with short serial intervals, such as SARS-Cov-2 and influenza, can quickly overwhelm healthcare resources in institutional settings such as jails. We assessed the impact of intake screening measures on the risk of SARS-CoV-2 outbreaks in this setting. We identified which elements of the intake process created the largest reductions in caseload. We implemented an individual-based simulation representative of SARS-Cov-2 transmission in a large urban jail utilizing testing at entry, quarantine, and post-quarantine testing to protect its general population from mass infection. We tracked the caseload under each scenario and quantified the impact of screening steps by varying quarantine duration, removing testing, and using a range of test sensitivities. We repeated the simulations under a range of transmissibility and community prevalence levels to evaluate the sensitivity of our results. We found that brief quarantine of newly incarcerated individuals separate from the existing population of the jail to permit pre-quarantine and end-of-quarantine tests reduced SARS-CoV-2 caseload 30-70% depending on test sensitivity. These results were robust to variation in the transmissibility. Further quarantine (up to 14 days) on average created only a 5% further reduction in caseload. A multilayered intake process is necessary to limit the spread of highly transmissible pathogens with short serial intervals. The pre-symptomatic phase means that no single strategy can be effective. We also show that shorter durations of quarantine combined with testing can be nearly as effective at preventing spread as longer-duration quarantine up to 14 days.
Identifiants
pubmed: 37669759
doi: 10.4269/ajtmh.22-0716
pii: tpmd220716
pmc: PMC10551074
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
874-880Subventions
Organisme : NIAID NIH HHS
ID : R01 AI146079
Pays : United States
Références
BMC Med. 2018 Aug 3;16(1):122
pubmed: 30071850
Am J Infect Control. 2021 Sep;49(9):1129-1135
pubmed: 33813042
J Gen Intern Med. 2020 Sep;35(9):2738-2742
pubmed: 32632787
Am J Public Health. 2021 May;111(5):907-916
pubmed: 33734845
MMWR Morb Mortal Wkly Rep. 2012 Apr 6;61(13):229-32
pubmed: 22475851
J Travel Med. 2022 May 31;29(3):
pubmed: 35262737
Int J Infect Dis. 2020 Apr;93:284-286
pubmed: 32145466
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Sci Rep. 2021 Jul 16;11(1):14604
pubmed: 34272449
Epidemics. 2022 Dec;41:100640
pubmed: 36274569
Clin Infect Dis. 2020 Jul 11;71(2):323-331
pubmed: 31425575
Am J Public Health. 2020 Jan;110(S1):S130-S136
pubmed: 31967898
BMJ Open. 2021 May 13;11(5):e046547
pubmed: 33986064
J Gen Intern Med. 2021 Oct;36(10):3096-3102
pubmed: 34291377
J Infect Dis. 2005 Feb 1;191 Suppl 1:S55-60
pubmed: 15627231
Infez Med. 2022 Sep 1;30(3):328-343
pubmed: 36148164
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
MMWR Morb Mortal Wkly Rep. 2021 Apr 02;70(13):478-482
pubmed: 33793462
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930